Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma

International Journal of COPD

Volumn 7, Issue , 2012, Pages 283-289

  Kitaguchi, Yoshiaki ^a   Komatsu, Yoshimichi ^a   Fujimoto, Keisaku ^b   Hanaoka, Masayuki ^a   Kubo, Keishi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

Author keywords

Asthma; COPD; HRCT; Inhaled corticosteroid; Pulmonary function

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTERIAL GAS; ARTICLE; ASTHMA; BLOOD GAS ANALYSIS; CHEST TIGHTNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; COUGHING; DISEASE EXACERBATION; DYSPNEA; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFLAMMATORY CELL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM EOSINOPHILIA; TREATMENT RESPONSE; WHEEZING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; ASTHMA; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPUTUM; STAINING AND LABELING; TREATMENT OUTCOME;

EID: 84860314088     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S30651     Document Type: Article

References (24)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2010. Available from: http://www.goldcopd.org/Guidelines/guideline-2010-gold-report.html. Accessed February 7, 2012.
2. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med. 2006;100(10):1742-1752.
3. Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology. 2006;11(6): 731-740.
4. Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax. 2003;58(4):322-327.
5. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004;126(1):59-65.
6. Diaz-Guzman E, Mannino DM. Airway obstructive diseases in older adults: from detection to treatment. J Allergy Clin Immunol. 2010;126(4):702-709.
7. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet. 2010;376(9743):803-813.
8. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8):728-735.
9. Fujimoto K, Kubo K, Matsuzawa Y, Sekiguchi M. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma. Chest. 1997;112(5):1241-1247.
10. Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33(4):379-387.
11. Roberts HR, Wells AU, Milne DG, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax. 2000;55(3):198-204.
12. Copley SJ, Wells AU, Muller NL, et al. Thin-section CT in obstructive pulmonary disease: discriminatory value. Radiology. 2002;223(3): 812-819.
13. Tzortzaki EG, Proklou A, Siafakas NM. Asthma in the elderly: can we distinguish it from COPD? J Allergy (Cairo). 2011;2011:843543.
14. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004;24(5):822-833.
15. Fujimoto K, Kubo K, Yamamoto H, Yamaguchi S, Matsuzawa Y. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest. 1999; 115(3):697-702.
16. Brightling CE, McKenna S, Hargadon B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. 2005;60(3):193-198.
17. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2010. Available from: http://www.ginasthma.org/guideline-report-2010.html. Accessed February 7, 2012.
18. Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742-750.
19. Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1(3):176-183.
20. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med. 2001;164(10 Pt 2):S28-S38.
21. Collard P, Njinou B, Nejadnik B, Keyeux A, Frans A. Single breath diffusing capacity for carbon monoxide in stable asthma. Chest. 1994;105(5):1426-1429.
22. Nakano Y, Muller NL, King GG, et al. Quantitative assessment of airway remodeling using high-resolution CT. Chest. 2002;122(Suppl 6): 271S-275S.
23. Little SA, Sproule MW, Cowan MD, et al. High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity. Thorax. 2002;57(3):247-253.
24. Vignola AM, Paganin F, Capieu L, et al. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J. 2004;24(6):910-917.